Pharmacological profile of antidepressants and related compounds at human monoamine transporters.
暂无分享,去创建一个
R. Blakely | E. Richelson | E Richelson | R D Blakely | M. Tatsumi | M Tatsumi | K Groshan | K. Groshan | M. Tatsumi
[1] S. Ross,et al. Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue. , 1969, European journal of pharmacology.
[2] E. Richelson,et al. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. , 1984, European journal of pharmacology.
[3] V. Ganapathy,et al. Sodium- and chloride-dependent, cocaine-sensitive, high-affinity binding of nisoxetine to the human placental norepinephrine transporter. , 1993, Biochemistry.
[4] L. Jellett,et al. Log-normal distribution of equiefective doses of norepinephrine and acetylcholine in several tissues. , 1972, The Journal of pharmacology and experimental therapeutics.
[5] E. Richelson,et al. Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. , 1993, Life sciences.
[6] R. Shank,et al. Preclinical evaluation of McN-5707 as a potential antidepressant. , 1987, The Journal of pharmacology and experimental therapeutics.
[7] R. Blakely,et al. Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter. , 1996, Molecular pharmacology.
[8] J. Glowinski,et al. Inhibition of Uptake of Tritiated-noradrenaline in the Intact Rat Brain by Imipramine and Structurally Related Compounds , 1964, Nature.
[9] J. Maas. Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression. , 1975, Archives of general psychiatry.
[10] D. Williams,et al. Two Affinity States for [3H]Imipramine Binding to the Human Platelet 5‐Hydroxytryptamine Carrier: An Explanation for the Allosteric Interaction Between 5‐Hydroxytryptamine and Imipramine , 1990, Journal of neurochemistry.
[11] R. Kuhn. The treatment of depressive states with G 22355 (imipramine hydrochloride). , 1958, The American journal of psychiatry.
[12] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[13] D Rodbard,et al. Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.
[14] Randy D. Blakely,et al. Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter , 1991, Nature.
[15] K. Fuxe,et al. Intercellular communication in the brain: Wiring versus volume transmission , 1995, Neuroscience.
[16] B. Koe. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. , 1976, The Journal of pharmacology and experimental therapeutics.
[17] R. Mcgee,et al. Inhibition of high affinity synaptosomal uptake systems by verapamil. , 1979, Molecular pharmacology.
[18] S. Tejani-butt. [3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding. , 1992, The Journal of pharmacology and experimental therapeutics.
[19] Oxman Te. Antidepressants and cognitive impairment in the elderly. , 1996 .
[20] E. Richelson. Pharmacology of antidepressants--characteristics of the ideal drug. , 1994, Mayo Clinic proceedings.
[21] P. Brust,et al. Specific binding of [3H]imipramine indicates the presence of a specific serotonin transport system on endothelial cells of porcine brain , 1995, Neuroscience Letters.
[22] A. Carlsson,et al. Central and peripheral monoaminergic membrane‐pump blockade by some addictive analgesics and antihistamines , 1969, The Journal of pharmacy and pharmacology.
[23] S. Hill,et al. Inhibition by H1-antihistamines of the uptake of noradrenaline and 5-HT into rat brain synaptosomes. , 1988, Biochemical pharmacology.
[24] R. Spealman,et al. Effects of cocaine and related drugs in nonhuman primates. I. [3H]cocaine binding sites in caudate-putamen. , 1989, The Journal of pharmacology and experimental therapeutics.
[25] R. Blakely,et al. Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands. , 1994, Molecular pharmacology.
[26] H. Okayama,et al. High-efficiency transformation of mammalian cells by plasmid DNA. , 1987, Molecular and cellular biology.
[27] R. Blakely,et al. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[28] M. Kuhar,et al. Methods in Neurotransmitter Receptor Analysis , 1990 .
[29] E. Richelson. Synaptic Effects of Antidepressants , 1996, Journal of clinical psychopharmacology.
[30] M. Worcel,et al. The effects of some slow channel blocking drugs on high affinity serotonin uptake by rat brain synaptosomes. , 1986, European journal of pharmacology.
[31] K. Neve,et al. Characterization of a recombinant human dopamine transporter in multiple cell lines. , 1995, The Journal of pharmacology and experimental therapeutics.
[32] R. Lefkowitz,et al. Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. , 1982, Molecular pharmacology.
[33] M. Caron,et al. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. , 1992, Molecular pharmacology.
[34] S. Kish,et al. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding. , 1994, Molecular pharmacology.
[35] D. Gehlert,et al. Comparison of (R)‐[3H] Tomoxetine and (R/S)‐[3H] Nisoxetine Binding in Rat Brain , 1995, Journal of neurochemistry.